Pretax income is the income that a company earns before paying income taxes. Ventyx Biosciences's pretax income for the
three
months ended in Dec. 2024 was $-29.35 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was $-135.12 Mil.
Ventyx Biosciences's pretax margin was %.
Ventyx Biosciences Pre-Tax Income Historical Data
The historical data trend for Ventyx Biosciences's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ventyx Biosciences's Pre-Tax Income
For the Biotechnology subindustry, Ventyx Biosciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ventyx Biosciences's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ventyx Biosciences's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Ventyx Biosciences's Pre-Tax Income falls into.
Ventyx Biosciences Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Ventyx Biosciences's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-135.12 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ventyx Biosciences (NAS:VTYX) Pre-Tax Income Explanation
Ventyx Biosciences's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ventyx Biosciences Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Ventyx Biosciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VTYX has been successfully added to your 